A new trading day began on Friday, with Glaukos Corporation (NYSE: GKOS) stock price up 3.19% from the previous day of trading, before settling in for the closing price of $129.25. GKOS’s price has ranged from $59.22 to $136.60 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 12.76%. Meanwhile, its annual earnings per share averaged 8.38%. With a float of $52.95 million, this company’s outstanding shares have now reached $54.95 million.
Let’s determine the extent of company efficiency that accounts for 907 employees. In terms of profitability, gross margin is 76.53%, operating margin of -35.54%, and the pretax margin is -46.18%.
Glaukos Corporation (GKOS) Insider Activity
As we move forward, let’s examine how large-scale investors are investing in this stock of the Medical Devices Industry. The insider ownership of Glaukos Corporation is 3.64%, while institutional ownership is 98.53%. The most recent insider transaction that took place on Sep 09 ’24, was worth 392,000. In this transaction Director of this company sold 3,000 shares at a rate of $130.67, taking the stock ownership to the 32,336 shares. Before that another transaction happened on Sep 09 ’24, when Company’s Director proposed sale 3,000 for $130.67, making the entire transaction worth $392,000.
Glaukos Corporation (GKOS) Earnings and Forecasts
In its latest quarterly report, released on 6/30/2024, the company reported earnings of -0.5 per share, which was $0.1 higher than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.42 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 8.38% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 8.00% during the next five years compared to -49.95% drop over the previous five years of trading.
Glaukos Corporation (NYSE: GKOS) Trading Performance Indicators
Here are Glaukos Corporation’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 4.67. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 21.45.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.20, a number that is poised to hit -0.48 in the next quarter and is forecasted to reach -1.35 in one year’s time.
Technical Analysis of Glaukos Corporation (GKOS)
Looking closely at Glaukos Corporation (NYSE: GKOS), its last 5-days average volume was 0.5 million, which is a drop from its year-to-date volume of 0.57 million. As of the previous 9 days, the stock’s Stochastic %D was 62.68%. Additionally, its Average True Range was 3.65.
During the past 100 days, Glaukos Corporation’s (GKOS) raw stochastic average was set at 88.99%, which indicates a significant increase from 87.67% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 33.54% in the past 14 days, which was higher than the 28.77% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $128.08, while its 200-day Moving Average is $108.76. However, in the short run, Glaukos Corporation’s stock first resistance to watch stands at $135.87. Second resistance stands at $138.37. The third major resistance level sits at $142.18. If the price goes on to break the first support level at $129.56, it is likely to go to the next support level at $125.75. Should the price break the second support level, the third support level stands at $123.25.
Glaukos Corporation (NYSE: GKOS) Key Stats
With a market capitalization of 7.33 billion, the company has a total of 50,368K Shares Outstanding. Currently, annual sales are 314,710 K while annual income is -134,660 K. The company’s previous quarter sales were 95,690 K while its latest quarter income was -50,550 K.
